Pennsylvania Attorney General Sues Over Alleged Insulin Price Inflation

Harrisburg Lancaster Lebanon York, PA, October 13, 2026 —

Pennsylvania’s attorney general has filed a lawsuit against pharmaceutical companies and pharmacy benefit managers, alleging they conspired to artificially inflate insulin prices and manipulate markets. The alleged conduct increased consumers’ out-of-pocket costs in the Harrisburg-Lancaster-Lebanon-York region, according to the available summary of the case.

The lawsuit places both drug manufacturers and pharmacy benefit managers among the parties accused. The summary does not identify the companies or managers named, say when the complaint was filed, or provide details about the specific conduct alleged. It also does not state the amount by which prices or consumer costs may have risen.

The claims are allegations in a lawsuit, not a finding that the defendants violated the law. The summary does not provide the defendants’ responses, the legal claims asserted, or any court rulings.

It is also unclear what remedies the attorney general is seeking. The summary does not specify whether the lawsuit requests financial compensation, changes to business practices, or other relief. No information was provided about the case’s current status or the next scheduled steps.

The reported impact is focused on consumers in the Harrisburg-Lancaster-Lebanon-York region. The summary does not establish whether the alleged effects were limited to that area or describe how individual consumers’ costs were calculated. Further details about the complaint and the parties’ positions were not provided.

Story summarized from the original created by Kyle Morgan on www.abc27.com, see more information here.

Media gallery